4-Methyl-3-sulfanylpentan-2-one
Common Name: |
4-Methyl-3-sulfanylpentan-2-one |
IUPAC Name: |
4-methyl-3-sulfanylpentan-2-one |
Molecular Formula: |
C14H20O2 |
SMILES: |
CC(C)C(C(=O)C)S |
Inchi: |
1S/C6H12OS/c1-4(2)6(8)5(3)7/h4,6,8H,1-3H3 |
Inchi Key: |
GVDXJPHOFKMDJV-UHFFFAOYSA-N |
Cas No: |
75832-79-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
220.31 |
Mass (g/mol) |
132.061 |
Molar Refractivity |
63.88 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
168 |
Vapor Pressure (mmHg@25.00 °C) |
1.7 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.79 |
LogP |
1.53 |
iLOGP |
2.59 |
XLOGP3 |
2.64 |
WLOGP |
2.79 |
MLOGP |
3.19 |
ESOL Log S |
-2.74 |
ESOL Solubility (mg/ml) |
0.404 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.84 |
Ali Solubility (mg/ml) |
0.32 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.12 |
Silicos-IT Solubility (mg/ml) |
1.66 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.77 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.61 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.92 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |